Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 10 1 2019
medline: 10 1 2019
entrez: 10 1 2019
Statut: ppublish

Résumé

In the version of this article initially published, the name of author Manuela Gago-Dominguez was misspelled as Manuela Gago Dominguez. The error has been corrected in the HTML and PDF version of the article.

Identifiants

DOI: 10.1038/s41588-018-0330-6 PMID: 30622367
pubmed: 30622367
doi: 10.1038/s41588-018-0330-6
pii: 10.1038/s41588-018-0330-6
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

363

Subventions

Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Fredrick R Schumacher (FR)

Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
Seidman Cancer Center, University Hospitals, Cleveland, OH, USA.
Royal Marsden NHS Foundation Trust, London, UK.
ORCID: 0000-0002-3073-7463

Ali Amin Al Olama (AAA)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. aa461@medschl.cam.ac.uk.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. aa461@medschl.cam.ac.uk.
Royal Marsden NHS Foundation Trust, London, UK. aa461@medschl.cam.ac.uk.

Sonja I Berndt (SI)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Royal Marsden NHS Foundation Trust, London, UK.

Sara Benlloch (S)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Institute of Cancer Research, London, UK.

Mahbubl Ahmed (M)

Institute of Cancer Research, London, UK.

Edward J Saunders (EJ)

Institute of Cancer Research, London, UK.

Tokhir Dadaev (T)

Institute of Cancer Research, London, UK.

Daniel Leongamornlert (D)

Institute of Cancer Research, London, UK.

Ezequiel Anokian (E)

Institute of Cancer Research, London, UK.

Clara Cieza-Borrella (C)

Institute of Cancer Research, London, UK.

Chee Goh (C)

Institute of Cancer Research, London, UK.

Mark N Brook (MN)

Institute of Cancer Research, London, UK.

Xin Sheng (X)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Laura Fachal (L)

Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain.
Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.

Joe Dennis (J)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.

Jonathan Tyrer (J)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.

Kenneth Muir (K)

Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
Warwick Medical School, University of Warwick, Coventry, UK.

Artitaya Lophatananon (A)

Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
Warwick Medical School, University of Warwick, Coventry, UK.

Victoria L Stevens (VL)

Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.

Susan M Gapstur (SM)

Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.

Brian D Carter (BD)

Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.

Catherine M Tangen (CM)

SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Phyllis J Goodman (PJ)

SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Ian M Thompson (IM)

CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA.

Jyotsna Batra (J)

Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.

Suzanne Chambers (S)

Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia.
Cancer Council Queensland, Fortitude Valley, Queensland, Australia.

Leire Moya (L)

Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.

Judith Clements (J)

Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.

Lisa Horvath (L)

Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia.
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

Wayne Tilley (W)

Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia.

Gail P Risbridger (GP)

Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia.
Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.

Henrik Gronberg (H)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Markus Aly (M)

Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Tobias Nordström (T)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.

Paul Pharoah (P)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.

Nora Pashayan (N)

Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.
Department of Applied Health Research, University College London, London, UK.

Johanna Schleutker (J)

Institute of Biomedicine, University of Turku, Turku, Finland.
Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.

Teuvo L J Tammela (TLJ)

Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.

Csilla Sipeky (C)

Institute of Biomedicine, University of Turku, Turku, Finland.

Anssi Auvinen (A)

Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.

Demetrius Albanes (D)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Stephanie Weinstein (S)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Alicja Wolk (A)

Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Niclas Håkansson (N)

Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Catharine M L West (CML)

Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK.

Alison M Dunning (AM)

Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.

Neil Burnet (N)

Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.

Lorelei A Mucci (LA)

Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA.

Edward Giovannucci (E)

Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA.

Gerald L Andriole (GL)

Washington University School of Medicine, St. Louis, MO, USA.

Olivier Cussenot (O)

UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France.
CeRePP, Tenon Hospital, Paris, France.

Géraldine Cancel-Tassin (G)

UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France.
CeRePP, Tenon Hospital, Paris, France.

Stella Koutros (S)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Laura E Beane Freeman (LE)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Karina Dalsgaard Sorensen (KD)

Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Torben Falck Orntoft (TF)

Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Michael Borre (M)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Urology, Aarhus University Hospital, Aarhus, Denmark.

Lovise Maehle (L)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Eli Marie Grindedal (EM)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

David E Neal (DE)

Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Cancer Research UK, Cambridge Research Institute, Cambridge, UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Jenny L Donovan (JL)

School of Social and Community Medicine, University of Bristol, Bristol, UK.

Freddie C Hamdy (FC)

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Richard M Martin (RM)

School of Social and Community Medicine, University of Bristol, Bristol, UK.

Ruth C Travis (RC)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Tim J Key (TJ)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Robert J Hamilton (RJ)

Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Neil E Fleshner (NE)

Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Antonio Finelli (A)

Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Sue Ann Ingles (SA)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Mariana C Stern (MC)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Barry S Rosenstein (BS)

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Sarah L Kerns (SL)

Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.

Harry Ostrer (H)

Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.

Yong-Jie Lu (YJ)

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.

Hong-Wei Zhang (HW)

Second Military Medical University, Shanghai, China.

Ninghan Feng (N)

Wuxi Second Hospital, Nanjing Medical University, Wuxi, China.

Xueying Mao (X)

Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.

Xin Guo (X)

Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Guomin Wang (G)

Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China.

Zan Sun (Z)

People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China.

Graham G Giles (GG)

Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Melissa C Southey (MC)

Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.

Robert J MacInnis (RJ)

Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Liesel M FitzGerald (LM)

Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Adam S Kibel (AS)

Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA.

Bettina F Drake (BF)

Washington University School of Medicine, St. Louis, MO, USA.

Ana Vega (A)

Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain.

Antonio Gómez-Caamaño (A)

Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.

Robert Szulkin (R)

Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden.
Scandinavian Development Services, Danderyd, Sweden.

Martin Eklund (M)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Manolis Kogevinas (M)

ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Javier Llorca (J)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
University of Cantabria-IDIVAL, Santander, Spain.

Gemma Castaño-Vinyals (G)

ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Kathryn L Penney (KL)

Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Meir Stampfer (M)

Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Jong Y Park (JY)

Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.

Thomas A Sellers (TA)

Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.

Hui-Yi Lin (HY)

Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.

Janet L Stanford (JL)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.

Cezary Cybulski (C)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Dominika Wokolorczyk (D)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Jan Lubinski (J)

International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Elaine A Ostrander (EA)

National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Milan S Geybels (MS)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Børge G Nordestgaard (BG)

Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

Sune F Nielsen (SF)

Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

Maren Weischer (M)

Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

Rasmus Bisbjerg (R)

Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

Martin Andreas Røder (MA)

Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Peter Iversen (P)

Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Katarina Cuk (K)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Bernd Holleczek (B)

Saarland Cancer Registry, Saarbrücken, Germany.

Christiane Maier (C)

Institute for Human Genetics, University Hospital Ulm, Ulm, Germany.

Manuel Luedeke (M)

Institute for Human Genetics, University Hospital Ulm, Ulm, Germany.

Thomas Schnoeller (T)

Department of Urology, University Hospital Ulm, Ulm, Germany.

Jeri Kim (J)

Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.

Christopher J Logothetis (CJ)

Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.

Esther M John (EM)

Cancer Prevention Institute of California, Fremont, CA, USA.
Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.

Manuel R Teixeira (MR)

Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.
Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.

Paula Paulo (P)

Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.

Marta Cardoso (M)

Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.

Susan L Neuhausen (SL)

Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Linda Steele (L)

Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Yuan Chun Ding (YC)

Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.

Kim De Ruyck (K)

Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium.

Gert De Meerleer (G)

Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium.

Piet Ost (P)

Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.

Azad Razack (A)

Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Jasmine Lim (J)

Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Soo-Hwang Teo (SH)

Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia.

Daniel W Lin (DW)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Urology, University of Washington, Seattle, WA, USA.

Lisa F Newcomb (LF)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Urology, University of Washington, Seattle, WA, USA.

Davor Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Marija Gamulin (M)

Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia.

Tomislav Kulis (T)

Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.

Radka Kaneva (R)

Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.

Nawaid Usmani (N)

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.

Sandeep Singhal (S)

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.

Chavdar Slavov (C)

Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria.

Vanio Mitev (V)

Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.

Matthew Parliament (M)

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.

Frank Claessens (F)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Steven Joniau (S)

Department of Urology, University Hospitals Leuven, Leuven, Belgium.

Thomas Van den Broeck (T)

Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Department of Urology, University Hospitals Leuven, Leuven, Belgium.

Samantha Larkin (S)

University of Southampton, Southampton General Hospital, Southampton, UK.

Paul A Townsend (PA)

Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK.

Claire Aukim-Hastie (C)

University of Surrey, Guildford, Surrey, UK.

Manuela Gago-Dominguez (M)

Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Jose Esteban Castelao (JE)

Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain.

Maria Elena Martinez (ME)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Monique J Roobol (MJ)

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Guido Jenster (G)

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Ron H N van Schaik (RHN)

Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.

Florence Menegaux (F)

Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.

Thérèse Truong (T)

Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.

Yves Akoli Koudou (YA)

Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.

Jianfeng Xu (J)

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.

Kay-Tee Khaw (KT)

Clinical Gerontology Unit, University of Cambridge, Cambridge, UK.

Lisa Cannon-Albright (L)

Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.

Hardev Pandha (H)

University of Surrey, Guildford, Surrey, UK.

Agnieszka Michael (A)

University of Surrey, Guildford, Surrey, UK.

Stephen N Thibodeau (SN)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Shannon K McDonnell (SK)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.

Daniel J Schaid (DJ)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.

Sara Lindstrom (S)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.

Constance Turman (C)

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Jing Ma (J)

Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

David J Hunter (DJ)

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Afshan Siddiq (A)

Genomics England, Queen Mary University of London, London, UK.

Federico Canzian (F)

Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Laurence N Kolonel (LN)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Loic Le Marchand (L)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Robert N Hoover (RN)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Mitchell J Machiela (MJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Zuxi Cui (Z)

Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.

Peter Kraft (P)

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Christopher I Amos (CI)

Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

David V Conti (DV)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Douglas F Easton (DF)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.

Fredrik Wiklund (F)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Stephen J Chanock (SJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.

Brian E Henderson (BE)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Zsofia Kote-Jarai (Z)

Institute of Cancer Research, London, UK.

Christopher A Haiman (CA)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

Rosalind A Eeles (RA)

Institute of Cancer Research, London, UK. ros.eeles@icr.ac.uk.
Royal Marsden NHS Foundation Trust, London, UK. ros.eeles@icr.ac.uk.

Classifications MeSH